{"id":398121,"date":"2020-12-11T07:33:29","date_gmt":"2020-12-11T12:33:29","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=398121"},"modified":"2020-12-11T07:33:29","modified_gmt":"2020-12-11T12:33:29","slug":"biosig-achieves-first-commercial-sale-of-three-pure-ep-systems","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/biosig-achieves-first-commercial-sale-of-three-pure-ep-systems\/","title":{"rendered":"BioSig Achieves First Commercial Sale of Three PURE EP Systems"},"content":{"rendered":"<h2>\nSale Marks Milestone for Company&#8217;s Commercial expansion at leading Center of Excellence<br \/>\n<\/h2>\n<div class=\"mw_release\">\n<p>Westport, CT, Dec.  11, 2020  (GLOBE NEWSWIRE) &#8212; BioSig Technologies, Inc. (NASDAQ: BSGM) (\u201cBioSig\u201d or the \u201cCompany\u201d), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced the purchase of three PURE EP\u2122 Systems by St. David\u2019s HealthCare of Austin, Texas. St. David\u2019s Medical Center, an HCA Healthcare owned hospital, has been recognized with a Malcolm Baldrige National quality award \u2013 the highest presidential honor for performance excellence.<\/p>\n<p>\u201cOur first commercial sale to St. David\u2019s HealthCare is an important milestone as we proceed in expanding our installed base nationwide,\u201d said Kenneth L. Londoner, Chairman, and CEO of BioSig Technologies, Inc. \u201cThis installation cements our valued relationship with St. David\u2019s and adds to the traction we are gaining in the electrophysiology (EP) market.<\/p>\n<p>BioSig installed the first PURE EP\u2122 System at St. David\u2019s Medical Center in November 2019. Shortly thereafter, Texas Cardiac Arrhythmia Institute (TCAI) at St. David\u2019s Medical Center conducted the first patient cases under the Company\u2019s clinical study, <em>\u201cNovel Cardiac Signal Processing System for Electrophysiology Procedures (PURE EP 2.0 Study).\u201d<\/em><\/p>\n<p>To date, more than 410 patient procedures have been conducted with the PURE EP\u2122 System across six different hospital sites in the United States, with over 200 procedures performed at TCAI.<\/p>\n<p>\n        <strong><br \/>\n          <br \/> About BioSig Technologies<br \/><\/strong>BioSig Technologies is a medical technology company commercializing a proprietary biomedical signal processing platform designed to\u00a0improve signal fidelity and uncover the full range of ECG and intra-cardiac signals\u00a0(<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=3vKjr_3oHowFz0Vy6KFZBUxsOxMdk1_R9_1R8trffBqOuqkHCeSWweQR4LKOpdRFoHlrc-Ezw--Q5BE6Co61xw==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>www.biosig.com<\/u><\/a>).<\/p>\n<p>The Company\u2019s first product,\u00a0PURE EP\u00e4 System\u00a0is a computerized system intended for acquiring, digitizing, amplifying, filtering, measuring and calculating, displaying, recording and storing of electrocardiographic and intracardiac signals for patients undergoing electrophysiology (EP) procedures in an EP laboratory.<\/p>\n<p>\n        <strong>Forward-looking Statements <\/strong>\n      <\/p>\n<p>This press release contains \u201cforward-looking statements.\u201d Such statements may be preceded by the words \u201cintends,\u201d \u201cmay,\u201d \u201cwill,\u201d \u201cplans,\u201d \u201cexpects,\u201d \u201canticipates,\u201d \u201cprojects,\u201d \u201cpredicts,\u201d \u201cestimates,\u201d \u201caims,\u201d \u201cbelieves,\u201d \u201chopes,\u201d \u201cpotential\u201d or similar words. Forward- looking statements are not guarantees of future performance, are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company\u2019s control, and cannot be predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with (i) the geographic, social and economic impact of COVID-19 on our ability to conduct our business and raise capital in the future when needed, (ii) our inability to manufacture our products and product candidates on a commercial scale on our own, or in collaboration with third parties; (iii) difficulties in obtaining financing on commercially reasonable terms; (iv) changes in the size and nature of our competition; (v) loss of one or more key executives or scientists; and (vi) difficulties in securing regulatory approval to market our products and product candidates. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company\u2019s filings with the Securities and Exchange Commission (SEC), including the Company\u2019s Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q. Investors and security holders are urged to read these documents free of charge on the SEC\u2019s website at http:\/\/www.sec.gov. The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise.\u00a0 <\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEwMDU4NyMzODY2OTg1IzIwMTgwNzg=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/d340801f-5534-4fb8-9914-1fdbb8b37674\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\">\n<pre>Andrew Ballou\r\nBioSig Technologies, Inc. \r\nVice President, Investor Relations \r\n54 Wilton Road, 2nd floor\r\nWestport, CT 06880\r\naballou@biosigtech.com\r\n203-409-5444, x133\r\n\r\n<\/pre>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Sale Marks Milestone for Company&#8217;s Commercial expansion at leading Center of Excellence Westport, CT, Dec. 11, 2020 (GLOBE NEWSWIRE) &#8212; BioSig Technologies, Inc. (NASDAQ: BSGM) (\u201cBioSig\u201d or the \u201cCompany\u201d), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced the purchase of three PURE EP\u2122 Systems by St. David\u2019s HealthCare of Austin, Texas. St. David\u2019s Medical Center, an HCA Healthcare owned hospital, has been recognized with a Malcolm Baldrige National quality award \u2013 the highest presidential honor for performance excellence. \u201cOur first commercial sale to St. David\u2019s HealthCare is an important milestone as we proceed in expanding our installed base nationwide,\u201d said Kenneth &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/biosig-achieves-first-commercial-sale-of-three-pure-ep-systems\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;BioSig Achieves First Commercial Sale of Three PURE EP Systems&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-398121","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>BioSig Achieves First Commercial Sale of Three PURE EP Systems - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/biosig-achieves-first-commercial-sale-of-three-pure-ep-systems\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BioSig Achieves First Commercial Sale of Three PURE EP Systems - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Sale Marks Milestone for Company&#8217;s Commercial expansion at leading Center of Excellence Westport, CT, Dec. 11, 2020 (GLOBE NEWSWIRE) &#8212; BioSig Technologies, Inc. (NASDAQ: BSGM) (\u201cBioSig\u201d or the \u201cCompany\u201d), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced the purchase of three PURE EP\u2122 Systems by St. David\u2019s HealthCare of Austin, Texas. St. David\u2019s Medical Center, an HCA Healthcare owned hospital, has been recognized with a Malcolm Baldrige National quality award \u2013 the highest presidential honor for performance excellence. \u201cOur first commercial sale to St. David\u2019s HealthCare is an important milestone as we proceed in expanding our installed base nationwide,\u201d said Kenneth &hellip; Continue reading &quot;BioSig Achieves First Commercial Sale of Three PURE EP Systems&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/biosig-achieves-first-commercial-sale-of-three-pure-ep-systems\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-11T12:33:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEwMDU4NyMzODY2OTg1IzIwMTgwNzg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biosig-achieves-first-commercial-sale-of-three-pure-ep-systems\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biosig-achieves-first-commercial-sale-of-three-pure-ep-systems\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"BioSig Achieves First Commercial Sale of Three PURE EP Systems\",\"datePublished\":\"2020-12-11T12:33:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biosig-achieves-first-commercial-sale-of-three-pure-ep-systems\\\/\"},\"wordCount\":601,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biosig-achieves-first-commercial-sale-of-three-pure-ep-systems\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEwMDU4NyMzODY2OTg1IzIwMTgwNzg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biosig-achieves-first-commercial-sale-of-three-pure-ep-systems\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biosig-achieves-first-commercial-sale-of-three-pure-ep-systems\\\/\",\"name\":\"BioSig Achieves First Commercial Sale of Three PURE EP Systems - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biosig-achieves-first-commercial-sale-of-three-pure-ep-systems\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biosig-achieves-first-commercial-sale-of-three-pure-ep-systems\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEwMDU4NyMzODY2OTg1IzIwMTgwNzg=\",\"datePublished\":\"2020-12-11T12:33:29+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biosig-achieves-first-commercial-sale-of-three-pure-ep-systems\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biosig-achieves-first-commercial-sale-of-three-pure-ep-systems\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biosig-achieves-first-commercial-sale-of-three-pure-ep-systems\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEwMDU4NyMzODY2OTg1IzIwMTgwNzg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEwMDU4NyMzODY2OTg1IzIwMTgwNzg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biosig-achieves-first-commercial-sale-of-three-pure-ep-systems\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BioSig Achieves First Commercial Sale of Three PURE EP Systems\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BioSig Achieves First Commercial Sale of Three PURE EP Systems - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/biosig-achieves-first-commercial-sale-of-three-pure-ep-systems\/","og_locale":"en_US","og_type":"article","og_title":"BioSig Achieves First Commercial Sale of Three PURE EP Systems - Market Newsdesk","og_description":"Sale Marks Milestone for Company&#8217;s Commercial expansion at leading Center of Excellence Westport, CT, Dec. 11, 2020 (GLOBE NEWSWIRE) &#8212; BioSig Technologies, Inc. (NASDAQ: BSGM) (\u201cBioSig\u201d or the \u201cCompany\u201d), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced the purchase of three PURE EP\u2122 Systems by St. David\u2019s HealthCare of Austin, Texas. St. David\u2019s Medical Center, an HCA Healthcare owned hospital, has been recognized with a Malcolm Baldrige National quality award \u2013 the highest presidential honor for performance excellence. \u201cOur first commercial sale to St. David\u2019s HealthCare is an important milestone as we proceed in expanding our installed base nationwide,\u201d said Kenneth &hellip; Continue reading \"BioSig Achieves First Commercial Sale of Three PURE EP Systems\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/biosig-achieves-first-commercial-sale-of-three-pure-ep-systems\/","og_site_name":"Market Newsdesk","article_published_time":"2020-12-11T12:33:29+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEwMDU4NyMzODY2OTg1IzIwMTgwNzg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biosig-achieves-first-commercial-sale-of-three-pure-ep-systems\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biosig-achieves-first-commercial-sale-of-three-pure-ep-systems\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"BioSig Achieves First Commercial Sale of Three PURE EP Systems","datePublished":"2020-12-11T12:33:29+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biosig-achieves-first-commercial-sale-of-three-pure-ep-systems\/"},"wordCount":601,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biosig-achieves-first-commercial-sale-of-three-pure-ep-systems\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEwMDU4NyMzODY2OTg1IzIwMTgwNzg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biosig-achieves-first-commercial-sale-of-three-pure-ep-systems\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/biosig-achieves-first-commercial-sale-of-three-pure-ep-systems\/","name":"BioSig Achieves First Commercial Sale of Three PURE EP Systems - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biosig-achieves-first-commercial-sale-of-three-pure-ep-systems\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biosig-achieves-first-commercial-sale-of-three-pure-ep-systems\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEwMDU4NyMzODY2OTg1IzIwMTgwNzg=","datePublished":"2020-12-11T12:33:29+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biosig-achieves-first-commercial-sale-of-three-pure-ep-systems\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/biosig-achieves-first-commercial-sale-of-three-pure-ep-systems\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biosig-achieves-first-commercial-sale-of-three-pure-ep-systems\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEwMDU4NyMzODY2OTg1IzIwMTgwNzg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEwMDU4NyMzODY2OTg1IzIwMTgwNzg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biosig-achieves-first-commercial-sale-of-three-pure-ep-systems\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"BioSig Achieves First Commercial Sale of Three PURE EP Systems"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/398121","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=398121"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/398121\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=398121"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=398121"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=398121"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}